Editorial Board
Majid Zeidi
University of Pennsylvania, Department of Dermatology · United States
Editorial leadership for Journal of Dermatologic Research And Therapy ISSN 2471-2175
Research interests
- Skin Disease Autoimmune Skin Disease Cutaneous Lupus Erythematosus Dermatomyositis Medicine Pathology Immunology Dermatopathology Autoimmune Skin Diseases Cutaneous Lupus Erythematosus Dermatomyositis
Biography
- Dr. Zeidi is a board certified Pathologist from TUMS.
- He completed his fellowship in dermatopathology at University of California, San Francisco (UCSF).
- He is currently working as Research Associate in department of dermatology at University of Pennsylvania.
- His current research interests include the cellular and molecular mechanisms that control immune-mediated inflammation of the skin diseases such as cutaneous lupus erythematosus and dermatomyositis.
- Dr. Zeidi is a member of the College of American Pathologists.
- He has authored or co-authored numerous articles.
Selected publications
- Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial 2022 cited 48×
- Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness 2021 cited 28×
- Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM 2022 cited 22×
- Increased MxA protein expression and dendritic cells in spongiotic dermatitis differentiates dermatomyositis from eczema in a single‐center case‐control study 2020 cited 11×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JDRT for your work?
This journal is guided by Majid Zeidi (University of Pennsylvania, Department of Dermatology) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.